ABACUS GLOBAL MANAGEMENT INC

Company Overview

Abacus Global Management Inc. is a Financial Services company in the Insurance - Life industry that specializes in life settlements, alternative asset management, wealth solutions, and technology-enabled longevity/mortality analytics. Its core business is buying existing life insurance policies in the secondary market, then either holding them to maturity or selling them to institutional investors, while also earning fees from origination and portfolio servicing. Recent acquisitions, including Carlisle Management Company, FCF Advisors, and AccuQuote, have expanded the platform into institutional asset management, ETFs, free-cash-flow strategies, and digital life insurance brokerage. The company reported strong 2025 growth, with revenue and gross profit more than doubling, reflecting higher policy sales, growing asset management fees, and broader contributions from acquired operations.

Executive Compensation Practices

Compensation at Abacus is likely tied closely to revenue growth, realized gains on policy sales, AUM expansion, fee income, and adjusted EBITDA, since those are the main value drivers in its business model. In a high-growth, acquisition-driven company like this, executives in the Financial Services sector often receive a mix of base salary, annual cash bonuses, equity awards, and performance-based stock vesting tied to operational scale and profitability metrics. The company’s 2025 results suggest pay incentives may also reward successful integration of acquisitions, expansion of recurring fee revenue, and efficient capital deployment in the life settlements portfolio. Because the business relies on proprietary underwriting, regulated origination channels, and capital-intensive portfolio management, compensation may also reflect long-term performance and risk controls rather than just short-term earnings.

Insider Trading Considerations

Insider trading activity in Abacus may be influenced by the company’s exposure to Level 3 valuation judgments, policy pricing, and timing of policy sales, all of which can materially affect reported earnings. Because the firm’s results depend heavily on institutional demand for life settlement assets, financing conditions, and acquisition integration, insiders may have especially strong informational advantages around quarterly performance and deal timing. The Insurance - Life industry also carries regulatory and disclosure constraints, which can lead insiders to be cautious around trading windows, especially when policy valuations or transaction pipelines are changing. For researchers and traders, insider buying may signal confidence in continued asset deployment, AUM growth, or acquisition synergies, while insider selling could reflect liquidity needs or diversification after large equity-based compensation grants.